Professor Sir Mark Caulfield delivering a keynote speech on Genomics England and the future of Precision Medicine
On 5th March 2020, Queen Mary University of London hosted a successful Precision Medicine Leadership event at St Bartholomew’s Great Hall. The event, run in partnership with One Nucleus & Cerba Research, explored new developments in the field of Precision Medicine as well as opportunities for academic/industrial collaboration.
Professor Sir Mark Caulfield delivered the keynote speech on Genomics England and the future of Precision Medicine, with other notable talks delivered by Prof. Claude Chelala (BCI) and Prof. David van Heel (Blizard Institute). Industry talks were given by Astra Zeneca, Precisionlife, Celyad, Cerba Research and Roche. The event concluded with a panel discussion involving Prof. Rakesh Uppal (BLS) and Jane Theaker (Kinomica).
Overall, the event was attended by 80 people from 31 companies spanning pharma, biotech, data analytics, IP law, medical writing, funding bodies and life sciences consulting - with many leads being generated. The success of the event highlights the appetite for academic/industry collaboration in Precision Medicine and the opportunities for QMUL academics in this area.
If you wish to engage with an industrial partner to facilitate your research, please contact the Business Development Team j.patel@qmul.ac.uk, d.milligan@qmul.ac.uk or d.collier@qmul.ac.uk, who will be happy to assist.